https://www.selleckchem.com/pr....oducts/pemigatinib-i
7% upon initiation of therapy to 29.9% within 1 year (p less then 0.001). Patients who subjectively rated their "overall respiratory health" as good to excellent increased from 13.6% upon initiation of therapy to 60.5% in 1 year (p less then 0.001) and those who rated their "ability to clear your lungs" as good to excellent increased from 13.9% to 76.6% (p less then 0.001). Conclusion NCFB patients showed improved self-reported outcomes associated with the initiation of HFCWO therapy as measured by number of hospitalizati
Like
Comment
Share
